Leaving Franklin Templeton

Clicking OK below will take you to an independent site. Information and services provided on this independent site are not reviewed by, guaranteed by, or endorsed by Franklin Templeton or its affiliates. Please keep in mind that this independent site's terms and conditions, privacy and security policies, or other legal information may be different from those of Franklin Templeton's site. Franklin Templeton is not liable for any direct or indirect technical or system issues, consequences or damages arising from your use of this independent website.

Publication Date: October 2025

From fast follower to fast leader: My journey into China’s biotech boom

China’s biotech push is reshaping global pharma and challenging US scientific leadership. After a research trip to Shanghai, Franklin Equity Group’s Evan McCulloch highlights the implications for US and European biotech firms.

From fast follower to fast leader: My journey into China’s biotech boom

Literature Code

Format

FEG25-CHBIO

PDF

Download

You have 0 Item in your cart

View cart to edit items, select amounts and checkout

Name Action

You have 0 Item in your cart

View cart to edit items, select amounts and checkout

Name Action

Sign in to view documents